Germany Retail Pharmacy Market Analysis Report 2022 to 2030

Germany Retail Pharmacy Market Analysis

$ 3999

Germany's retail pharmacy market is projected to grow from $38.01 Bn in 2022 to $56.59 Bn by 2030, registering a CAGR of 5.1% during the forecast period of 2022–2030. The key drivers of the German retail pharmacy market include an ageing population, increased demand for prescription drugs, and government regulations. Rossmann is a top German drugstore chain with over 4,000 stores nationwide.

ID: IN10DEPH021 CATEGORY: Pharmaceuticals GEOGRAPHY: Germany AUTHOR: Shivam Zalke

Buy Now

Germany Retail Pharmacy Market Executive Summary

Germany's retail pharmacy market is projected to grow from $38.01 Bn in 2022 to $56.59 Bn by 2030, registering a CAGR of 5.1% during the forecast period of 2022–30.

The retail pharmacy market in Germany is a highly consolidated market, with a small number of large players dominating the industry. These players include Rossmann, dm-drogerie Markt, and Müller.

The German retail pharmacy market is heavily regulated by the government through the Federal Association of German Pharmacies (ABDA) and the Federal Institute for Drugs and Medical Devices (BfArM). These organizations are responsible for ensuring that pharmacies and pharmacy staff meet certain standards and comply with relevant laws and regulations.

In recent years, the German government has introduced several policies aimed at reducing costs and improving the efficiency of the healthcare system. For example, the government has implemented a reference pricing system that sets the maximum price that can be charged for certain drugs. Additionally, the government has also introduced measures to increase the use of generic drugs in order to reduce costs.

The German retail pharmacy market is also characterized by a high level of competition among retailers, with many pharmacies offering a wide range of products and services, including over-the-counter drugs, cosmetics, and health-related products.

In summary, the retail pharmacy market in Germany is heavily influenced by government policies and regulations, and changes in these policies can have a significant impact on the market. Additionally, the market is characterized by a high level of competition among retailers, and a strong focus on reducing costs and increasing efficiency in the healthcare system.

Germany retail pharmacy market report 2022 to 2030

Market Dynamics

Market Drivers

The key drivers of the German retail pharmacy market include an aging population, increased demand for prescription drugs, and government regulations. The aging population in Germany is leading to a higher demand for prescription drugs and over-the-counter (OTC) products, which is driving the growth of the retail pharmacy market. Additionally, government regulations and reimbursement policies play a significant role in the market, as they determine the prices of drugs and the reimbursement rates for pharmacies. Another important factor is the growing number of international and online pharmacies entering the German market, which is increasing competition and driving down prices.

Market Restraints

The key restraints of the German retail pharmacy market include price controls and regulations, reimbursement policies, and the growing number of international and online pharmacies. Price controls and regulations, such as the statutory reimbursement system, limit the prices that pharmacies can charge for drugs, which can negatively impact their profitability.

Reimbursement policies also play a role in the market, as they determine the amount of money that pharmacies receive from the government for each prescription they fill. This can affect their profitability and their ability to invest in new technologies and services.

The growing number of international and online pharmacies entering the German market is increasing competition and driving down prices, which can also negatively impact the profitability of local pharmacies. Additionally, the German retail pharmacy market is highly consolidated, with a few large companies dominating the market, which can limit the opportunities for small and independent pharmacies to succeed.

Competitive Landscape

Key Players

The key players in the Germany retail pharmacy market include:

Rossmann: It is a German drugstore chain with over 4,000 stores across the country.
dm-drogerie market: It is a German discount store chain, with over 3,500 stores across the country.
Müller: It is a German drugstore chain with over 1,200 stores across the country.
Schlecker: It is a German pharmacy chain with over 1,000 stores across the country.
DocMorris: It is an online pharmacy based in Germany.
QVC: It is a German television and online retailer, with a focus on health and beauty products.
Sanicare: It is a German online pharmacy.
Shop-Apotheke Europe: It is an online pharmacy based in Germany

These players occupy a major share of the market, they have a strong brand image and an extensive network of stores across the country. They continuously innovate, adapt and expand their service offerings to cater to the changing customer needs and stay competitive in the market.

Healthcare Policies and Regulatory Landscape

The healthcare policies and regulatory landscape in Germany play a significant role in the retail pharmacy market. The German healthcare system is based on a statutory health insurance system, which is funded by social security contributions and taxes. This system regulates the prices of drugs and the reimbursement rates for pharmacies.

The Federal Joint Committee (G-BA) is responsible for setting the reimbursement rates for drugs in Germany. The G-BA is also responsible for determining which drugs are eligible for reimbursement and at what price. This can have a significant impact on the profitability of pharmacies, as they are only reimbursed a set amount for each drug they sell.

The German Pharmaceutical Industry Association (BPI) represents the interests of the pharmaceutical industry in Germany and is responsible for setting prices for drugs. The BPI works closely with the government and other stakeholders to develop and implement policies that promote the development and availability of new drugs in the market.

The German government also regulates the number of pharmacies that can operate in a given area to ensure fair competition among pharmacies and to prevent oversupply. The German Pharmacies Act (ApBetrO) is the main legislation that regulates the operations of pharmacies in Germany. It sets out the requirements for opening and operating a pharmacy, including the qualifications and training required for pharmacists.

In summary, the German healthcare system, the Federal Joint Committee, the German Pharmaceutical Industry Association, and the German Pharmacies Act play a crucial role in regulating the retail pharmacy market in Germany.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Germany Retail Pharmacy Market Segmentation

Pharmacy Product

It mainly includes Pharmaceutical products and it provides information for medical treatments.

Prescription
OTC

Pharmacy Type

Hospital Pharmacy
Retail Pharmacy
Chain
Independent
Others
ePharmacy
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.